Skip to main content
Smart Investors Daily
CL

NYSE · CLNY

Colony Capital, Inc.

Real Estate · REIT - Diversified

$8.50

Up+$0.00 (+0.00%)

Updated Aug 14, 2026, 7:00 AM

SID Score

Composite research score

Smart Money

Institutional and insider signal

Market cap
1.36B
P/E ratio
2.21
Dividend yield
0.00%
52-week range
— – —
Volume
7.11M
Avg. volume
3.29M

Price performance

CLNY price history

1M range · 0 trading sessions · Daily adjusted prices

CLNY does not have enough price history for the selected period.

Data unavailable

The requested market data was not found.

Latest CLNY news

The latest Smart Investors Daily articles mentioning CLNY.

CLNY research

Overview

Company profile and research snapshot.

Company profile

Colony Capital, Inc. (NYSE: CLNY) is a leading global investment firm with a heritage of identifying and capitalizing on key secular trends in real estate. The Company manages an approximately $47 billion portfolio of real assets on behalf of its shareholders and limited partners, including over $23 billion in digital real estate investments through Digital Colony, its digital infrastructure platform. Colony Capital, structured as a REIT, is headquartered in Los Angeles with key offices in Boca Raton, New York, and London, and has over 350 employees across 20 locations in 11 countries.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Average target
Implied upside
Analysts
CLNY recent ratings
DateFirmRatingTarget
Jun 21, 2021Wells FargoOverweight
May 12, 2020B. Riley FBRBuy
Mar 11, 2020B. Riley FBRBuy
Mar 6, 2018WedbushOutperform
Jan 31, 2018B. Riley FBRBuy
Open full forecast

News briefing

No generated briefing is available yet.

Benzinga · Jun 21, 2021

Benzinga's Top Ratings Upgrades, Downgrades For June 21, 2021

Upgrades B of A Securities upgraded the previous rating for Cimarex Energy Co (NYSE:XEC) from Neutral to Buy. For the first quarter, Cimarex Energy had an EPS of $1.98, compared to year-ago quarter EPS of $0.58. According to B of A Securities, the prior rating for Marathon Oil Corp (NYSE:MRO) was changed from Underperform to Neutral. In the first quarter, Marathon Oil showed an EPS of $0.21, compared to $0.16 from the year-ago quarter. At the moment, the stock has a 52-week-high of $14.16 and a 52-week-low of $3.73. Marathon Oil closed at $12.57 at the end of the last trading period. Scotiabank upgraded the previous rating for Westlake Chemical Corp (NYSE:WLK) from Sector Underperform to Sector Perform. In the first quarter, Westlake Chemical showed an EPS of $1.87, compared to $0.65 from the year-ago quarter. At the moment, the stock has a 52-week-high of $106.47 and a 52-week-low of $50.38. Westlake Chemical closed at $91.31 at the end of the last trading period. For Eastman Chemical Co (NYSE:EMN), Scotiabank upgraded the previous rating of Sector Perform to Sector Outperform. Eastman Chemical earned $2.13 in the first quarter, compared to $2.03 in the year-ago quarter. The current stock performance of Eastman Chemical shows a 52-week-high of $130.47 and a 52-week-low of $65.86. Moreover, at the end of the last trading period, the closing price was at $114.15. According to B. Riley Securities, the prior rating for MarineMax Inc (NYSE:HZO) was changed from Neutral to Buy. In the second quarter, MarineMax showed an EPS of $1.69, compared to $0.23 from the year-ago quarter. At the moment, the stock has a 52-week-high of $70.89 and a 52-week-low of $20.12. MarineMax closed at $45.19 at the end of the last trading period. According to B of A Securities, the prior rating for Liberty Oilfield Services Inc (NYSE:LBRT) was changed from Underperform to Neutral. Liberty Oilfield Services earned $0.17 in the first quarter, compared to $0.02 in the year-ago quarter. The current stock performance of Liberty Oilfield Services shows a 52-week-high of $17.78 and a 52-week-low of $4.91. Moreover, at the end of the last trading period, the closing price was at $14.14. See all analyst ratings upgrades.   Downgrades According to Barrington Research, the prior rating for Sykes Enterprises Inc (NASDAQ:SYKE) was changed from Outperform to Market Perform. In the first quarter, Sykes Enterprises showed an EPS of $0.73, compared to $0.44 from the year-ago quarter. The stock has a 52-week-high of $53.93 and a 52-week-low of $24.75. At the end of the last trading period, Sykes Enterprises closed at $53.45. B of A Securities downgraded the previous rating for Range Resources Corp (NYSE:RRC) from Neutral to Underperform. In the first quarter, Range Resources showed an EPS of $0.30, compared to $0.04 from the year-ago quarter. The stock has a 52-week-high of $16.32 and a 52-week-low of $5.08. At the end of the last trading period, Range Resources closed at $14.14. For CAI International Inc (NYSE:CAI), William Blair downgraded the previous rating of Outperform to Market Perform. In the first quarter, CAI International showed an EPS of $1.85, compared to $0.67 from the year-ago quarter. The stock has a 52-week-high of $56.13 and a 52-week-low of $15.51. At the end of the last trading period, CAI International closed at $56.05. Baird downgraded the previous rating for Sykes Enterprises Inc (NASDAQ:SYKE) from Outperform to Neutral. Sykes Enterprises earned $0.73 in the first quarter, compared to $0.44 in the year-ago quarter. The stock has a 52-week-high of $53.93 and a 52-week-low of $24.75. At the end of the last trading period, Sykes Enterprises closed at $53.45. For Arcturus Therapeutics Holdings Inc (NASDAQ:ARCT), Barclays downgraded the previous rating of Equal-Weight to Underweight. In the first quarter, Arcturus Therapeutics showed an EPS of $2.15, compared to $0.67 from the year-ago quarter. The current stock performance of Arcturus Therapeutics shows a 52-week-high of $129.71 and a 52-week-low of $24.87. Moreover, at the ...Full story available on Benzinga.com

Zacks Investment Research · May 6, 2021

Colony Capital (CLNY) Q1 FFO and Revenues Miss Estimates

Colony Capital (CLNY) delivered FFO and revenue surprises of -75.00% and -71.83%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.